EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Cucurbitacin E’s Anti-Cancer Effects on HCT116 Human Colon Cancer Cells by Controlling Expression and Phosphorylation levels of Caspase-9, eIF-2α, and ATF-4

Anil Kumar Yadav, Byeong-Churl Jang

Keimyung Medical Journal · 2020

DOI: 10.46308/kmj.2020.00059 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Keimyung Medical Journal, 2020. Verfasst von Anil Kumar Yadav und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cucurbitacin E is a pivotal member of the cucurbitacin family and has been shown to have anti-cancer effects.However, until now, the anti-cancer effect and mode of action of cucurbitacin E in human colon cancer cells remain unclear.In this study, we investigated whether cucurbitacin E inhibits the growth of HCT116 human colorectal cancer cells.Treatment of cucurbitacin E at 1 µM markedly reduced the survival of HCT116 cells.Moreover, treatment of cucurbitacin E at 1 µM caused nuclear DNA fragmentation in HCT116 cells, pointing out its apoptosis-inducing effect.Treatment of cucurbitacin E at 1 µM also led to the activation of caspase-9 and poly(ADP-ribose) polymerase (PARP) cleavage without affecting expression of death receptor (DR)-4/5 in HCT116 cells.Furthermore, while treatment of cucurbitacin E at 1 µM had no effect on expression of Mcl-1, it largely increased expression and phosphorylation of eukaryotic translation initiation factor-2α (eIF-2α) and activating transcription factor-4 (ATF-4) in HCT116 cells.Treatment of cucurbitacin E at 1 µM further up-regulated phosphorylation of extracellular signal-regulated kinase-1/2 (ERK-1/2), but not c-Jun N-terminal kinase1/2 (JNK-1/2), in HCT116 cells.However, treatment with PD98059, an inhibitor of ERK-1/2, that strongly blocked activation of ERK-1/2 had no effect on reduction of survival of HCT116 cells treated with cucurbitacin E at 1 µM.Taken together, these findings demonstrate that cucurbitacin E at 1 µM has strong anti-survival and pro-apoptotic effects on HCT116 cells, which are mediated through control of the expression and phosphorylation levels of caspase-9, PARP, eIF-2α, and ATF-4.

Zitieren

APA

Yadav, A. K., & Jang, B. (2020). Cucurbitacin E’s Anti-Cancer Effects on HCT116 Human Colon Cancer Cells by Controlling Expression and Phosphorylation levels of Caspase-9, eIF-2α, and ATF-4. Keimyung Medical Journal. https://doi.org/10.46308/kmj.2020.00059

Vancouver

Yadav AK, Jang B. Cucurbitacin E’s Anti-Cancer Effects on HCT116 Human Colon Cancer Cells by Controlling Expression and Phosphorylation levels of Caspase-9, eIF-2α, and ATF-4. Keimyung Medical Journal. 2020. doi:10.46308/kmj.2020.00059

BibTeX
@article{Yadav2020,
  author = {Yadav, Anil Kumar and Jang, Byeong-Churl},
  title = {Cucurbitacin E’s Anti-Cancer Effects on HCT116 Human Colon Cancer Cells by Controlling Expression and Phosphorylation levels of Caspase-9, eIF-2α, and ATF-4},
  journal = {Keimyung Medical Journal},
  year = {2020},
  doi = {10.46308/kmj.2020.00059}
}
Kostenlos starten →